KRMD — Koru Medical Systems Share Price
0.000.00%
Last trade - 00:00- $112.12m
- $103.12m
- $33.65m
- 77
- 24
- 57
- 52
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.67 | ||
| Price to Tang. Book | 6.97 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.33 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -32.2% | ||
| Return on Equity | -32.64% | ||
| Operating Margin | -19.16% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 24.18 | 23.49 | 27.9 | 28.52 | 33.65 | 38.43 | 44.37 | 7.75% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -89.6 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
KORU Medical Systems, Inc. designs, manufactures, and markets proprietary portable and advanced medical devices primarily for the subcutaneous drug delivery market. The Company is focused on home and specialty infusion solutions. Its focus is primarily concentrated on its mechanical infusion products, the FREEDOM Infusion Systems, which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. The devices are used for infusions administered at home and in alternate care settings. Its infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
Directors
- R. John Fletcher CHM (75)
- Linda Tharby PRE (50)
- Karen Fisher CFO (55)
- Manuel Marques COO (48)
- James Beck DRC (72)
- Daniel Goldberger DRC (62)
- Robert Allen IND (64)
- David Anderson IND (67)
- Kathy Frommer IND (61)
- Joseph Manko IND (54)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 11th, 2023
- Public Since
- October 27th, 1993
- No. of Shareholders
- 431
- No. of Employees
- 80
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 45,390,996
- Address
- 100 Corporate Drive, MAHWAH, 07430
- Web
- https://www.korumedical.com/
- Phone
- +1 8454692042
- Auditors
- McGrail Merkel Quinn & Associates
Upcoming Events for KRMD
Q1 2025 KORU Medical Systems Inc Earnings Call
KORU Medical Systems Inc Annual Shareholders Meeting
Similar to KRMD
Accelerate Diagnostics
NASDAQ Capital Market
Adagio Medical Holdings
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
FAQ
What is the Koru Medical Systems share price?
As of Today at 21:39 UTC, shares in Koru Medical Systems are trading at $2.47. This share price information is delayed by 15 minutes.
How has the Koru Medical Systems share price performed this year?
Shares in Koru Medical Systems last closed at $2.47 and the price had moved by +12.79% over the past 365 days. In terms of relative price strength the Koru Medical Systems share price has outperformed the S&P500 Index by +4.1% over the past year.
What are the analyst and broker recommendations for Koru Medical Systems?
The overall consensus recommendation for Koru Medical Systems is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Koru Medical Systems dividend yield?
Koru Medical Systems does not currently pay a dividend.
Does Koru Medical Systems pay a dividend?
Koru Medical Systems does not currently pay a dividend.
When does Koru Medical Systems next pay dividends?
Koru Medical Systems does not currently pay a dividend.
How do I buy Koru Medical Systems shares?
To buy shares in Koru Medical Systems you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Koru Medical Systems?
As of the previous close price of $2.47, shares in Koru Medical Systems had a market capitalisation of $112.12m.
Where are Koru Medical Systems shares listed?
Here are the trading details for Koru Medical Systems:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: KRMD
What kind of share is Koru Medical Systems?
Based on an overall assessment of its quality, value and momentum Koru Medical Systems is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Koru Medical Systems share price forecast for 2025?
The analyst consensus target price for shares in Koru Medical Systems is $5.70. That is 130.77% above the last closing price of $2.47.
Analysts covering Koru Medical Systems currently have a consensus Earnings Per Share (EPS) forecast of -$0.10 for the next financial year.
Find out moreWhat is the trend in the Koru Medical Systems share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Koru Medical Systems. Over the past six months, its share price has outperformed the S&P500 Index by +2.9%.
As of the last closing price of $2.47, shares in Koru Medical Systems were trading -19.82% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Koru Medical Systems PE Ratio?
The Koru Medical Systems PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.47.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Koru Medical Systems?
Koru Medical Systems' management team is headed by:
- R. John Fletcher - CHM
- Linda Tharby - PRE
- Karen Fisher - CFO
- Manuel Marques - COO
- James Beck - DRC
- Daniel Goldberger - DRC
- Robert Allen - IND
- David Anderson - IND
- Kathy Frommer - IND
- Joseph Manko - IND